Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
104 participants
OBSERVATIONAL
2024-04-01
2034-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Changes in Renal Cortical and Medullary Blood Flow by Contrast Ultrasound
NCT00631553
A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy
NCT01538433
Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease
NCT01430494
24-hour Urinary Electrolyte Excretion in Chronic Kidney Disease
NCT05550467
Variability in Micro-CT Imaging Results to Quantify Dialyzer Clotting
NCT06140563
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with de novo nephrotic syndrome
Observation
Observation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observation
Observation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Plasma albumin \< 36 g/L
* Urine protein \>3.5 g/day or urine protein/creatinine-ratio (UPCR) \> 3.5 or urine albumin/creatinine-ratio (UACR) \>2200 mg/g
* Planned kidney biopsy
* Able to give written informed consent
Exclusion Criteria
* Previously undergone a kidney biopsy
* Unable to understand written information in Danish
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Iain Bressendorff
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Iain Bressendorff
MD PhD
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Nephrotic Syndrome Cohort
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.